Billions of people around the world lack access to life‐saving medicines. While this is because of a number of synergistic causes, one critical factor is the prohibitively high cost of patent‐monopolized medications. Provisions currently being negotiated for the Trans‐Pacific Partnership agreement (TPP) risk exacerbating this situation, which for many is a matter of life and death.
Contributing Organization:
HIV Legal Network
HIV Legal Network
Contact person:
Terry Gould
Terry Gould
Publication Date:
2013
2013
Area(s) of focus:
Download resource(s):
Copyright:
Contact the contributor for copyright permissions.
Contact the contributor for copyright permissions.
Record last updated:
Mon, 26/05/2014 - 14:54
Mon, 26/05/2014 - 14:54